Versant Capital Management’s Intuitive Surgical ISRG Stock Holding History

Versant Capital Management’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294K	Sell	740 -326	-31%	-$142K	0.03%	476
2026 Q1	$491K	Sell	1,066 -191	-15%	-$96.6K	0.05%	262
2025 Q4	$712K	Sell	1,257 -96	-7%	-$51.1K	0.09%	143
2025 Q3	$605K	Buy	1,353 +393	+41%	+$189K	0.08%	161
2025 Q2	$522K	Sell	960 -232	-19%	-$121K	0.08%	165
2025 Q1	$590K	Buy	1,192 +504	+73%	+$279K	0.1%	123
2024 Q4	$359K	Buy	688 +148	+27%	+$77.1K	0.08%	122
2024 Q3	$265K	Buy	540 +137	+34%	+$63.8K	0.06%	130
2024 Q2	$179K	Buy	403 +89	+28%	+$35.4K	0.05%	144
2024 Q1	$125K	Hold	314	–	–	0.04%	162
2023 Q4	$106K	Sell	314 -7	-2%	-$2.09K	0.03%	181
2023 Q3	$93.8K	Sell	321 -7	-2%	-$2.19K	0.03%	186
2023 Q2	$112K	Buy	328 +7	+2%	+$2.12K	0.04%	173
2023 Q1	$82K	Buy	321 +12	+4%	+$2.96K	0.03%	193
2022 Q4	$82K	Hold	309	–	–	0.03%	168
2022 Q3	$58K	Hold	309	–	–	0.02%	192
2022 Q2	$62K	Hold	309	–	–	0.02%	193
2022 Q1	$93K	Hold	309	–	–	0.03%	174
2021 Q4	$111K	Hold	309	–	–	0.04%	147
2021 Q3	$102K	Hold	309	–	–	0.04%	149
2021 Q2	$95K	Hold	309	–	–	0.04%	147
2021 Q1	$76K	Hold	309	–	–	0.03%	176
2020 Q4	$84K	Hold	309	–	–	0.03%	159
2020 Q3	$73K	Hold	309	–	–	0.03%	162
2020 Q2	$58K	Hold	309	–	–	0.03%	186
2020 Q1	$51K	Hold	309	–	–	0.03%	178
2019 Q4	$60K	Sell	309 -6	-2%	-$1.12K	0.03%	186
2019 Q3	$56K	Sell	315 -45	-13%	-$7.78K	0.03%	197
2019 Q2	$62K	Sell	360 -114	-24%	-$19.5K	0.03%	185
2019 Q1	$90K	Sell	474 -15	-3%	-$2.67K	0.04%	152
2018 Q4	$78K	Hold	489	–	–	0.04%	162
2018 Q3	$93K	Sell	489 -9	-2%	-$1.6K	0.04%	155
2018 Q2	$79K	Buy	498 +3	+0.6%	+$458	0.03%	186
2018 Q1	$68K	Hold	495	–	–	0.03%	212
2017 Q4	$60K	Hold	495	–	–	0.02%	252
2017 Q3	$57K	Hold	495	–	–	0.03%	230
2017 Q2	$51K	Hold	495	–	–	0.03%	244
2017 Q1	$42K	Hold	495	–	–	0.02%	315
2016 Q4	$34K	Sell	495 -18	-4%	-$1.32K	0.02%	406
2016 Q3	$41K	Buy	513 +27	+6%	+$2.07K	0.02%	312
2016 Q2	$35K	Hold	486	–	–	0.02%	339
2016 Q1	$32K	Buy	486 +27	+6%	+$1.67K	0.02%	359
2015 Q4	$27K	Buy	+459	New	+$25.8K	0.02%	410

Other funds holding ISRG

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

HAM

Hyperion Asset Management Brisbane, Australia $3.77B AUM 16.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Versant Capital Management's ISRG Position: Q2 2026 in Review

Versant Capital Management reduced its Intuitive Surgical (ISRG) stake by 31% in Q2 2026, selling an estimated $142K and leaving 740 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #476.

Versant Capital Management first reported a position in ISRG in Q4 2015 and has held it in 43 quarters since. The position peaked at $712K in Q4 2025. 636 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

Versant Capital Management held 740 shares of Intuitive Surgical worth $294K as of Q2 2026.
Versant Capital Management sold 326 Intuitive Surgical shares in Q2 2026, an estimated $142K.
Intuitive Surgical made up 0.03% of Versant Capital Management's portfolio in Q2 2026, its #476 holding.
Versant Capital Management first reported a position in Intuitive Surgical in Q4 2015 and has held it in 43 quarters since.
Versant Capital Management's Intuitive Surgical position peaked at $712K in Q4 2025.
636 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.